ask="N/A"
ask_size="N/A"
average_daily_volume="21414"
bid="N/A"
bid_size="N/A"
book_value="0.07"
change="+0.51"
change_from_200_day_moving_average="-0.71"
change_from_50_day_moving_average="0.00"
change_from_52_week_high="-2.48"
change_From_52_week_low="1.21"
change_in_percent="+20.40%"
close="3.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.00"
ebitda="-56.01M"
eps_estimate_current_year="-2.35"
eps_estimate_next_quarter="-0.56"
eps_estimate_next_year="-2.25"
ex_dividend_date="N/A"
float_shares="9243000"
high="3.28"
high_52_weeks="5.49"
last_trade_date="12/30/2016"
last_trade_price="3.01"
last_trade_size="300"
last_trade_time="3:59pm"
low="2.41"
low_52_weeks="1.80"
market_capitalization="68.63M"
moving_average_200_day="3.72"
moving_average_50_day="3.01"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="11.00"
open="2.56"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-18.99%"
percent_change_from_50_day_moving_average="+0.04%"
percent_change_from_52_week_high="-45.17%"
percent_change_from_52_week_low="+66.85%"
previous_close="2.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="36.23"
price_per_sales="19.13"
revenue="2.98M"
shares_outstanding="22802000"
short_ratio="0.54"
stock_exchange="NGM"
symbol="ONS"
volume="134540"
weeks_range_52="1.80 - 5.49"
